These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 24666139)

  • 1. Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients.
    Ismaila A; Corriveau D; Vaillancourt J; Parsons D; Stanford R; Su Z; Sampalis JS
    Curr Med Res Opin; 2014 Jul; 30(7):1417-25. PubMed ID: 24666139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients.
    Ismaila A; Corriveau D; Vaillancourt J; Parsons D; Dalal A; Su Z; Sampalis JS
    Curr Med Res Opin; 2014 Jul; 30(7):1427-36. PubMed ID: 24666181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
    Delea TE; Hagiwara M; Stanford RH; Stempel DA
    Clin Ther; 2008 Mar; 30(3):560-71. PubMed ID: 18405796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of combination fluticasone propionate and salmeterol or inhaled corticosteroids on asthma-related outcomes in a Medicare-eligible population.
    Stanford RH; Blanchette CM; Roberts MH; Petersen H; Fuhlbrigge AL
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):343-51. PubMed ID: 23083688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherence.
    Blais L; Forget A; Ramachandran S
    Clin Ther; 2010 Jul; 32(7):1320-8. PubMed ID: 20678680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies.
    Delea TE; Hagiwara M; Dalal AA; Stanford RH; Blanchette CM
    Curr Med Res Opin; 2009 Jan; 25(1):1-13. PubMed ID: 19210134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-care utilization and costs with fluticasone propionate and fluticasone propionate/salmeterol in asthma patients at risk for exacerbations.
    Hagiwara M; Delea TE; Stanford RH
    Allergy Asthma Proc; 2014; 35(1):54-62. PubMed ID: 24433597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs*.
    Delea TE; Stanford RH; Hagiwara M; Stempel DA
    Curr Med Res Opin; 2008 Dec; 24(12):3435-42. PubMed ID: 19032125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An observational study of fixed dose combination fluticasone propionate/salmeterol or fluticasone propionate alone on asthma-related outcomes .
    Stanford RH; Fuhlbrigge A; Riedel A; Rey GG; Stempel DA
    Curr Med Res Opin; 2008 Nov; 24(11):3141-8. PubMed ID: 18838055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies.
    Stoloff SW; Stempel DA; Meyer J; Stanford RH; Carranza Rosenzweig JR
    J Allergy Clin Immunol; 2004 Feb; 113(2):245-51. PubMed ID: 14767437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administrative claims analysis of asthma-related health care utilization for patients who received inhaled corticosteroids with either montelukast or salmeterol as combination therapy.
    Allen-Ramey FC; Bukstein D; Luskin A; Sajjan SG; Markson LE
    J Manag Care Pharm; 2006 May; 12(4):310-21. PubMed ID: 16792437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of asthma exacerbation, asthma-related health care utilization and costs, and adherence to controller therapy in patients with asthma receiving fluticasone propionate/salmeterol inhalation powder 100 μg/50 μg versus mometasone furoate inhalation powder.
    Hagiwara M; Delea TE; Stanford RH
    J Asthma; 2013 Apr; 50(3):287-95. PubMed ID: 23305687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
    Friedman HS; Yawn BP
    Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to asthma controller medication regimens.
    Stempel DA; Stoloff SW; Carranza Rosenzweig JR; Stanford RH; Ryskina KL; Legorreta AP
    Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effectiveness of budesonide-formoterol combination and fluticasone-salmeterol combination for asthma management: a United States retrospective database analysis.
    Tunceli O; Williams SA; Kern DM; Elhefni H; Pethick N; Wessman C; Zhou S; Trudo F
    J Allergy Clin Immunol Pract; 2014; 2(6):719-26. PubMed ID: 25439363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
    O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
    Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease.
    Dalal AA; Roberts MH; Petersen HV; Blanchette CM; Mapel DW
    Int J Chron Obstruct Pulmon Dis; 2010 Dec; 6():13-22. PubMed ID: 21311689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma.
    Lyseng-Williamson KA; Plosker GL
    Pharmacoeconomics; 2003; 21(13):951-89. PubMed ID: 12959627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of fixed combination of fluticasone and salmeterol on asthma drug utilization, asthma drug cost, and episodes of asthma exacerbations.
    Brixner DI; Lenhart G; Young DC; Samuelson WM
    Curr Med Res Opin; 2007 Nov; 23(11):2887-95. PubMed ID: 17922979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.